MEMariela Verónica Escande

Mariela Verónica Escande

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mariela Verónica Escande has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Camila L. Zold

    Systems Neuroscience Group, IFIBIO Bernardo Houssay, CONICET and Universidad de Buenos Aires, Department of Physiology and Biophysics, University of Buenos Aires School of Medicine, Buenos Aires, Argentina 1121

    1 shared publication
  • Camila L. Zold

    Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, Neural Circuit Physiol Lab,Syst Neurosci Grp, 2155 Paraguay St, RA-1121 Buenos Aires, DF, Argentina

    1 shared publication
  • Camila Lidia Zold

    Instituto de Fisiología y Biofísica Bernardo Houssay (IFIBIO-Houssay), Grupo de Neurociencia de Sistemas, Universidad de Buenos Aires y Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires 1121, Argentina

    1 shared publication
  • Ettel Keifman

    Instituto Cajal, Consejo Superior de Investigaciones Científicas, CSIC, Madrid, Spain

    1 shared publication
  • Irene R. E. Taravini

    Experimental Parkinsonism Group, ININFA, CONICET, and University of Buenos Aires, Buenos Aires, Argentina 1121, and Experimental Neurobiology Laboratory, University of Entre Ríos, Concepción del Uruguay, Entre Ríos, Argentina 2820

    1 shared publication
  • Juan Emilio Belforte

    Universidad de Buenos Aires y Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de Fisiología y Biofísica "Bernardo Houssay" (IFIBIO-Houssay), Grupo de Neurociencia de Sistemas, Buenos Aires 1121, Argentina

    1 shared publication

Latest Publications

  • Open Access

    Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease

    by Mariela V. Escande, Irene R. E. Taravini, Camila L. Zold, Juan E. Belforte, M. Gustavo Murer

    The characteristic slowness of movement in Parkinson's disease relates to an imbalance in the activity of striatal medium spiny neurons (MSNs) of the direct (dMSNs) and indirect (iMSNs) pathways. However, it is still unclear whether this imbalance emerges during the asymptomatic phase of the disease or if it correlates with symptom severity. Here, we have usedin vivojuxtacellular recordings and transgenic mice showing MSN-type-specific expression of fluorescent proteins to examine striatal imbalance after lesioning dopaminergic neurons of the substantia nigra. Multivariate clustering analysis of behavioral data discriminated 2 groups of dopamine-lesioned mice: asymptomatic (42 ± 7% dopaminergic neuron loss) and symptomatic (85 ± 5% cell loss). Contrary to the view that both pathways have similar gain in control conditions, dMSNs respond more intensely than iMSNs to cortical inputs in control animals. Importantly, asymptomatic mice show significant functional disconnection of dMSNs from motor cortex without changes in iMSN connectivity. Moreover, not only the gain but also the timing of the pathways is altered in symptomatic parkinsonism, where iMSNs fire significantly more and earlier than dMSNs. Therefore, cortical drive to dMSNs decreases after partial nigrostriatal lesions producing no behavioral impairment, but additional alterations in the gain and timing of iMSNs characterize symptomatic rodent parkinsonism.SIGNIFICANCE STATEMENTPrevailing models of Parkinson's disease state that motor symptoms arise from an imbalance in the activity of medium spiny neurons (MSNs) from the direct (dMSNs) and indirect (iMSNs) pathways. Therefore, it is hypothesized that symptom severity and the magnitude of this imbalanced activity are correlated. Using a mouse model of Parkinson's disease, we found that behaviorally undetectable nigrostriatal lesions induced a significant disconnection of dMSNs from the motor cortex. In contrast, iMSNs show an increased connectivity with the motor cortex, but only after a severe dopaminergic lesion associated with an evident parkinsonian syndrome. Overall, our data suggest that the lack of symptoms after a partial dopaminergic lesion is not due to compensatory mechanisms maintaining the activity of both striatal pathways balanced.


  • Oscillations in the basal ganglia in Parkinson's disease: Role of the striatum

    by Mariano Andrés Belluscio, Mariela Verónica Escande, Ettel Keifman, Luis Alberto Riquelme, Mario Gustavo Murer, Camila Lidia Zold